INHIBITORS OF HIV-1 PROTEASE CONTAINING THE NOVEL AND POTENT (R)-(HYDROXYETHYL)SULFONAMIDE ISOSTERE

[1] Darke P L, 1994, Adv Pharmacol, V25, P399, DOI 10.1016/S1054-3589(08)60438-X

[2] THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 153 - 164

[3] DISCOVERY OF A NOVEL CLASS OF POTENT HIV-1 PROTEASE INHIBITORS CONTAINING THE (R)-(HYDROXYETHYL) UREA ISOSTERE [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) : 288 - 291

[4] HIV PROTEASE - A NOVEL CHEMOTHERAPEUTIC TARGET FOR AIDS [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) : 2305 - 2314

[5] ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4686 - 4690

[6] HTLV-III GAG PROTEIN IS PROCESSED IN YEAST-CELLS BY THE VIRUS POL-PROTEASE [J]. SCIENCE, 1986, 231 (4745) : 1580 - 1584

[7] A SYNTHESIS OF PROTECTED AMINOALKYL EPOXIDES FROM ALPHA-AMINO-ACIDS [J]. JOURNAL OF ORGANIC CHEMISTRY, 1987, 52 (08) : 1487 - 1492

[8] RECENT ADVANCES IN THE DESIGN OF HIV PROTEINASE-INHIBITORS [J]. ANTIVIRAL RESEARCH, 1992, 17 (04) : 265 - 278

[9] PHOSPHONAMIDATES AND PHOSPHONAMIDATE ESTERS AS HIV-1 PROTEASE INHIBITORS [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (11) : 653 - +

[10] SYNTHESIS OF PEPTIDES CONTAINING THE BETA-SUBSTITUTED AMINOETHANE SULFINAMIDE OR SULFONAMIDE TRANSITION-STATE ISOSTERE DERIVED FROM AMINO-ACIDS [J]. TETRAHEDRON LETTERS, 1992, 33 (42) : 6389 - 6392

[1] Darke P L, 1994, Adv Pharmacol, V25, P399, DOI 10.1016/S1054-3589(08)60438-X

[2] THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 153 - 164

[3] DISCOVERY OF A NOVEL CLASS OF POTENT HIV-1 PROTEASE INHIBITORS CONTAINING THE (R)-(HYDROXYETHYL) UREA ISOSTERE [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) : 288 - 291

[4] HIV PROTEASE - A NOVEL CHEMOTHERAPEUTIC TARGET FOR AIDS [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) : 2305 - 2314

[5] ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4686 - 4690

[6] HTLV-III GAG PROTEIN IS PROCESSED IN YEAST-CELLS BY THE VIRUS POL-PROTEASE [J]. SCIENCE, 1986, 231 (4745) : 1580 - 1584

[7] A SYNTHESIS OF PROTECTED AMINOALKYL EPOXIDES FROM ALPHA-AMINO-ACIDS [J]. JOURNAL OF ORGANIC CHEMISTRY, 1987, 52 (08) : 1487 - 1492

[8] RECENT ADVANCES IN THE DESIGN OF HIV PROTEINASE-INHIBITORS [J]. ANTIVIRAL RESEARCH, 1992, 17 (04) : 265 - 278

[9] PHOSPHONAMIDATES AND PHOSPHONAMIDATE ESTERS AS HIV-1 PROTEASE INHIBITORS [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (11) : 653 - +

[10] SYNTHESIS OF PEPTIDES CONTAINING THE BETA-SUBSTITUTED AMINOETHANE SULFINAMIDE OR SULFONAMIDE TRANSITION-STATE ISOSTERE DERIVED FROM AMINO-ACIDS [J]. TETRAHEDRON LETTERS, 1992, 33 (42) : 6389 - 6392